Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

NCT01898416 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER_GOV

Sponsor class

Conditions

The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an
Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After
Surgical Resection

Interventions

DRUG: 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.

Sponsor

michal roll